February 20, 2021
https://www.ibtimes.co.in/covid-19-vaccines-india-decoded-833409
The #Baylor College of Medicine constructs “RBD N1C1” was selected as the final vaccine antigen candidate on the basis of its manufacturability, due to the yields of protein antigen achieved, ease of process steps and favorable formulation aspects.
It is currently in phase II and will probably move on phase III soon. Awaiting more information on this candidate.
No comments:
Post a Comment